论文部分内容阅读
中医研究院中药研究所“猪苓多糖实验研究与临床研究”的科研成果于1983月1月25日通过鉴定。鉴定委员会认为,这是一项中西医结合的具有国内先进水平的科研成果。猪苓多糖是从常用中药猪苓中提取出来的。通过六年多来大量的实验研究,证明猪苓多糖对几种实验动物模型具有明显的抗肿瘤作用。预防性给药对移植性肿瘤的生长也有一定抑制作用。在临床验证中,猪苓多糖单用或伍用化疗治疗晚期原发性肺癌(鳞癌为主)共200余例、急性白血病近40例、肝癌和鼻咽癌等68例,均证明
The research results of the Institute of Traditional Chinese Medicine of the Institute of Traditional Chinese Medicine of the Institute of Traditional Chinese Medicine and the “Experimental Research and Clinical Research of Polyporus Polysaccharides” passed the identification on January 25, 1983. The appraisal committee believes that this is a combination of Chinese and Western medicine with scientific research achievements of the domestic advanced level. Polyporus umbellatus polysaccharides are extracted from commonly used traditional Chinese medicine piglets. Through a large number of experimental studies over the past six years, it has been proved that Polyporus umbellatus polysaccharide has obvious anti-tumor effects on several experimental animal models. Prophylactic administration also has a certain inhibitory effect on the growth of transplanted tumors. In clinical verification, there were more than 200 cases of advanced primary lung cancer (mainly squamous cell carcinoma), 40 cases of acute leukemia, liver cancer and nasopharyngeal carcinoma, etc.